Shearman & Sterling advised Bridgepoint on the sale of LGC to Kohlberg Kravis Roberts (KKR) for an undisclosed sum. 

LGC is an international life sciences company creating measurement and testing solutions for companies across the world, operating globally in 22 countries. It focuses on three distinct areas: the manufacture and distribution of reference materials, proprietary genomic products and the provision of analytical and genomics testing services. With over three- quarters of its customers in the private sector and the balance in government and the public sector, LGC serves the pharma, AgBio, food and environmental sectors.

Bridgepoint is a major international private equity group focused on investing in market-leading businesses. Established more than 25 years ago, it has over €20 billion of committed capital from a global investor base. 

The Shearman & Sterling team advising on the transaction was led by partners Mark Soundy (London-M&A) and Sarah Priestley (London-Tax) and included partner James Webber (London-Antitrust). Associates Paul Pasalic and Mathew Sherman (both London-M&A), George Milton and Gabriella Griggs (both London-Antitrust), and trainees Claire Hunter (London-M&A) and Charlotte Rice (London-Tax) also worked on the transaction. 

Recently, Shearman & Sterling advised Bridgepoint on the acquisition of Moneycorp (August 2014), and advised management on Bridgepoint’s sale of Quilter Cheviot (October 2014).